The hackers have targeted Johnson & Johnson, Novavax and AstraZeneca, all of which are developing COVID-19 vaccine candidates. South Korean drugmakers with COVID-19 drugs in clinical testing have also been targeted, including Genexine, Shin Poong and Celltrion, sources told the WSJ.
Though it is unclear whether the hackers obtained the information they were seeking, they have been launching cyberattacks on these six drugmakers since August, sources told the WSJ. They also said the cyberattacks contained digital footprints used in previous North Korean hacking campaigns targeting the U.S. Department of State and South Korea’s unification ministry.
More articles on cybersecurity:
Nearly 1M health records breached in November
Montefiore alerts patients of privacy breach linked to billing scam: 4 details
Beware of insider cyber threats, AMA warns hospitals
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
